Mesenchymal Stem Cells as a Treatment for Acute Respiratory Distress Syndrome
Michael Biskup Introduction. Acute Respiratory Distress Syndrome (ARDS) is an inflammatory reaction of the lungs to cellular damage. ARDS commonly develops after trauma, infection, pleuritis, and aspiration. Hypoxemic respiratory failure is a defining characteristic. In the beginning stages of ARDS, the body releases inflammatory mediators such as IL-1. Neutrophils then…